about
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor t...
Read More
78.56
0.96
(1.24%)
12.2M
XNYS Volume
XNYS 26 Sep, 2025 5:30 PM (EDT)
High Financial Strength
Affordable Valuation
Technically Neutral
Strong Performer, Under Radar
These stocks are with good quality scores and with strong financials. They are affordably priced stocks and can give good returns
View Similar
Embed DVM
Merck & Company Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..